1 Value Stock for Long-Term Investors and 2 Facing Challenges [Yahoo! Finance]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Yahoo! Finance
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models. Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here is one value stock with strong fundamentals and two climbing an uphill battle. Two Value Stocks to Sell: Disney (DIS) Forward P/E Ratio: 13.9x Founded by brothers Walt and Roy, Disney (NYSE:DIS) is a multinational entertainment conglomerate, renowned for its theme parks, movies, television networks, and merchandise. Why Do We Think DIS Will Underperform? Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 9.5% over the last five years was below our standards for the consumer discretionary sector Operating margin of 14.8% falls short of the industry average, and the smaller profit doll
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal [Yahoo! Finance]Yahoo! Finance
- 1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma and J&J partner to develop autoimmune treatment [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated DiseasesGlobeNewswire
RPRX
Sec Filings
- 4/2/26 - Form 4
- 4/1/26 - Form 144
- 4/1/26 - Form 13F-NT
- RPRX's page on the SEC website